This atlas provides a practically applicable didatic case-based guide to the use of cardiac imaging in patient care during and after cancer therapy. It features detailed information on a variety of imaging modalities, including transesophageal echocardiography, magnetic resonance angiography and positron emission tomography. A range of actual patient presentations are included covering both diagnosis and management during curative and palliative surgery, as well as cancer pharmacotherapy with the use of drugs including Trastuzumab, Anthracycline, Cisplatin and Carboplatin. Topics relevant to survivorship are also described. Atlas of Imaging in Cardio-Oncology enables the reader to develop a deep understanding of how to utilise a variety of imaging modalities used in cardio-oncology in a range of scenarios. It provides a critical and timely resource for the trainee and experienced cardiologist, oncologist and radiologist.

Covering a broad range of topics with side-by-side radiographic images, Multimodal Imaging Atlas of Cardiac Masses provides basic-to-advanced clinical tips on the use, clinical applications, and interpretation of cardiac imaging for cardiac masses. Written by a team of international experts in cardiac imaging, cardiac pathology, and cardiac surgery, this title features separate chapters on imaging modalities, anatomic pitfalls, cardiac thrombus, benign tumors, infectious lesions, and malignant tumors. This practical title is an essential guide for cardiologists, interventional cardiologists, cardiac surgeons, radiologists, and others to recognize the typical features of these uncommon conditions and to formulate team-based treatment plans for these complex patients. - Covers multimodal cardiac imaging depicting all types of cardiac masses. - Includes anatomic pitfalls, artifacts, differential diagnoses, and metastasis. - Features 600 figures and 100 video clips of cardiac imaging, including echocardiography, CT, CMR, and PET, with photos of histopathologic findings and masses after surgery. - Includes important clinical points on interpretation and differentiation of benign tumors, malignant tumors, and artifacts.

A companion to the 6th edition Nuclear Cardiac Imaging, the atlas provides an expansive set of case examples and information not included in the textbook. An abundance of multiple-choice exam questions throughtout serves as a challenging self-assessment tool for readers testing their knowledge.

This issue of Cardiology Clinics, guest edited by Dr. Monika Jacquelina Leja, will focus on Cardio-Oncology. Topics include, but are not limited to, Anthracycline Cardiomyopathy in Cancer Patients, Common Vascular Toxicities of Cancer Therapies, Cardiotoxicity of Immune Therapy, 5 FU Related Cardiotoxicity, Trastuzumab Induced Cardiotoxicity, Echocardiography Imaging of Cardiotoxicity, MRI Imaging of Cardiotoxicity, Cardiomyopathy Prevention in Cancer Patients, Radiation Related Cardiovascular Disease, Electrophysiology in Cardio-Oncology, Cardiac Interventional Procedures in Cardio-Oncology Patients, Diagnosis and Treatment of Amyloid Related to Myeloid Dyscrasias, Carcinoid Heart Disease, Cardiac Tumors, Cardiovascular Toxicities in Pediatric Cancer Survivors, and Developing a Cardio-Oncology Practice Nuts and Bolts: Coding and Billing.

The atlas provides a clear, concise, yet comprehensive review of common cardiovascular diseases occurring in patients with cancer. Cancer and cardiovascular disease are the two most common conditions worldwide. In clinical practice we frequently encounter patients who have established cardiovascular disease and subsequently develop cancer or are survivors of cancer with subsequent cardiovascular complications related to chemotherapy and or radiation. Most of the chapters are case based, followed by images and a discussion on current (evidence based, wherever available) investigations and treatment outline.

This book offers a practical guidance to healthcare professionals interested in learning how to make adequate clinically-oriented use of cardiovascular MRI. Thanks to its case-based approach, it provides a detailed guide to MRI applications in the most common clinical cardiovascular scenarios. Chapters describe a number of real clinical cases, including concise clinical data, clear descriptions of the most relevant information obtained from MRI and of their meaning in terms of patient management. Emphasis is placed on traditional as well as newer MRI techniques, always keeping a practical format, focused on the hands-on knowledge required for an accurate image interpretation. In the online version, the text of each case is supplemented with additional images and videos, certainly making this book a useful resource for understanding how MRI principles apply to real clinical cardiovascular situations.

Clinical Cardio-oncology is a comprehensive, clinically focused title for cardiologists, oncologists, and specialists in cardio-oncology programs who need up-to-date knowledge about the cardiovascular effects of cancer treatment, especially on long-term cancer survivors. This brand-new resource covers the implementation of cardio-oncology into your practice, while a strong focus on patient management offers helpful information on coordinating care before, during, and after therapy. Its highly organized four-section format allows readers to quickly and easily locate relevant information. - Comprised of four sections for quick and easy reference: Oncology and Hematology Principles; Cardiac Complications from Cancer Therapy; Coordination of Care; and Cardio-oncology in Practice. - Provides expert wisdom from cardio-oncology authorities around the world, as well as consultation and perspectives from pioneers in the field of oncology. - Highlights the principles of cancer therapies, including radiation and tumor therapy, as well as pre-, intra-, and post-therapy cardiology evaluation. - Boasts chapters on implementing cardio-oncology into practice: primary cancer centers, comprehensive referral centers, group practices, and educational needs and goals for fellowship programs. - Advises on how to coordinate care for the patient at every stage of treatment (pre-therapy, during therapy, after therapy, and end-of-life). - Presents detailed information on various cardiac complications from cancer therapy, such as cardiomyopathy, vascular disease, arrhythmias, and hypertension. - Teaches the principles of oncology and hematology with coverage of different therapy types and cardiac tumors. - Includes a comprehensive drug guide.

Cancer and cardiovascular disease (CVD) are the two most common causes of mortality and morbidity worldwide. The incidence of both cancer and cardiovascular disease increases with age. With increased life expectancy, the burden of both these diseases will increase substantially in coming years. Patients with CVD share multiple common risk factors and lifestyle behaviors in addition to frequently suffering from multiple comorbid conditions. Tobacco use, hypertension, high cholesterol, diabetes, physical inactivity, and poor nutrition are all established risk factors of heart disease. Patients with diseases such as breast cancer may develop CVD from treatment, such as use of chemotherapy and RT. Effects on the heart are a potentially significant and serious clinical problem in radiation therapy treatment of breast cancer. Over the course of the past 50 years, there have been great advances in the delivery of RT due to the development of new techniques, beam energy, improvement in imaging modalities, and development of image registration strategies. It is hypothesized that cardiac damage from RT is correlated to the dose absorbed by the heart and differs between left- and right-breast radiotherapy. The damage to cardiac micro- and macro-vasculature is the pathophysiological cause of RT-related heart disease. Given the growing clinical relevance of cardio-oncology, this Frontiers in Oncology Research Topic provides a venue for disseminating focused reviews and cutting edge research in this quickly growing field. We encourage submission of original papers and reviews dealing with cardiac toxicity after breast cancer treatment, motion management to reduce cardiac exposure, imaging to evaluate potential cardiac toxicities and primary prevention of cardiac disease in the breast cancer patient.